Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L5IN
|
|||
Former ID |
DNC002567
|
|||
Drug Name |
4-Amino Hexanoic Acid
|
|||
Synonyms |
4-Aminohexanoic acid; 5415-99-6; Hexanoic acid, 4-amino-; g-aminocaproic acid; 4-ethyl aminobutyric acid; AC1L3CX4; SCHEMBL900872; CTK1H4537; MolPort-006-169-599; ALBB-018090; NSC11326; NSC-11326; AKOS000277394; AKOS017258812; Hexanoic acid, 4-amino-, hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C6H13NO2
|
|||
Canonical SMILES |
CCC(CCC(=O)O)N
|
|||
InChI |
1S/C6H13NO2/c1-2-5(7)3-4-6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1
|
|||
InChIKey |
ROFNJLCLYMMXCT-YFKPBYRVSA-N
|
|||
CAS Number |
CAS 1334472-86-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA transaminase (ABAT) | Target Info | Inhibitor | [1] |
BioCyc | GABA shunt | |||
Valine degradation | ||||
Beta-alanine degradation | ||||
4-aminobutyrate degradation | ||||
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Valine, leucine and isoleucine degradation | ||||
beta-Alanine metabolism | ||||
Propanoate metabolism | ||||
Butanoate metabolism | ||||
Metabolic pathways | ||||
GABAergic synapse | ||||
Panther Pathway | Aminobutyrate degradation | |||
Pyrimidine Metabolism | ||||
Gamma-aminobutyric acid synthesis | ||||
Pathwhiz Pathway | Aspartate Metabolism | |||
Glutamate Metabolism | ||||
Beta-Alanine Metabolism | ||||
Valine, Leucine and Isoleucine Degradation | ||||
Propanoate Metabolism | ||||
WikiPathways | GABA synthesis, release, reuptake and degradation | |||
Alanine and aspartate metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.